Baichun Hu

8PUBLICATIONS
16CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designPharmacogenomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 20, 2025
Discovery and Administration Optimization of Novel Selective CDK9 Inhibitor, 1-7a-B1, for Improved Pharmacokinetics and Antitumor Efficacy In Vivo.

Jing Xu, Ye Zhong, Mengdi Qin

|Jul 03, 2024
Docking Score ML: Target-Specific Machine Learning Models Improving Docking-Based Virtual Screening in 155 Targets.

Haihan Liu, Baichun Hu, Peiying Chen

|Apr 03, 2024
Uncovering the selectivity mechanism of phosphodiesterase 7A/8A inhibitors through computational studies.

Zhijian Wang, Shizun Wang, Hanxun Wang

|Mar 15, 2024
Identification of a Novel Selective CDK9 Inhibitor for the Treatment of CRC: Design, Synthesis, and Biological Activity Evaluation.

Ye Zhong, Jing Xu, Ruochen Zhou

|Oct 25, 2022
Selectivity mechanism of muscarinic acetylcholine receptor antagonism through in silico investigation.

Lu Chen, Baichun Hu, Hanxun Wang

|Jul 06, 2022
Selectivity mechanism of BCL-XL/2 inhibition through in silico investigation.

Jiasi Luan, Baichun Hu, Shizhun Wang

Pageof 2

Frequent Collaborators

4 joint publications

Jian Wang

4 joint publications

Shizun Wang

3 joint publications

Maosheng Cheng

2 joint publications

Hanxun Wang